Disease Intelligence & Analytics
Expert curated disease intelligence and analytics to size disease markets, guide strategy, and stay ahead of clinical and competitive shifts.
Expert curated disease intelligence solutions for every disease market
DRG Disease Intelligence & Analytics delivers end to end disease intelligence by bringing together epidemiology driven population insights and expert curated market understanding. This disease analytics platform helps life sciences teams size opportunities, understand disease evolution, and guide confident clinical and commercial strategy.
The advantages of a smarter strategy with disease analytics
Make confident decisions with a clear view of patient opportunity
Understand the true size, structure, and evolution of patient populations so you can ground decisions in a reliable view of disease dynamics. With a clear foundation of disease intelligence, teams can align on assumptions, strengthen planning, and make more confident strategic choices across the lifecycle.
Know every disease market
Gain a comprehensive, expert‑curated view of patient populations, treatment pathways, competitive dynamics, and epidemiology—so your teams always understand the full story behind every disease.
Identify opportunities before your competitors do
Spot emerging therapies, biosimilar‑driven shifts, unmet needs, and evolving standards of care early—helping you size markets, prioritize indications, and position assets for maximum impact.
Move faster with expert‑curated intelligence
Skip time‑consuming manual research. Disease Intelligence & Analytics distils complex disease landscapes into clear, actionable insights—accelerating onboarding, scenario planning, and strategic direction for cross‑functional teams.
Comprehensive disease intelligence across every indication and opportunity
Disease Intelligence & Analytics integrates epidemiology driven population insights and expert curated market analysis to support confident disease level decision making across the product lifecycle. Each intelligence suite is purpose built to answer different disease level questions—together forming a complete disease analytics foundation.
DRG Market Assessment
Expert‑authored disease insights that integrate treatment pathways, unmet needs, competitive landscapes, physician and payer perspectives and indication‑level 10-year market forecasts—supporting strategic decisions across the product lifecycle.
DRG Epidemiology Intelligence
Gold‑standard epidemiology built by a global team of epidemiologists and therapy‑area experts, delivering fast, reliable incidence and prevalence data, 10–20‑year forecasts, and granular segmentation across 1,000+ diseases, including rare and niche conditions.
Questions we help answer
These disease level intelligence questions define smarter portfolio, clinical, and commercial decision making.
- How large are the patient and sub‑population segments, and how will they evolve over time?
- How are treatment patterns, standards of care, and competitive dynamics changing within this disease area – and what does this mean for market performance?
- Where are the highest‑value market opportunities—and which indications or markets should we prioritize next?
- How do we compare opportunities across disease areas to prioritize investment, resources, and portfolio strategy?
Why leading teams choose disease intelligence platform?
1000+
100+
40+
85+
240+
30+ years
Resources
Seven companies forging new paths in women’s health
Women’s health: from neglect to global investment priority For decades, women’s health has been underfunded and understudied, despite women representing half the global population. Conditions that disproportionately affect women, such…
Frequently asked questions
Disease intelligence combines epidemiology, market understanding, and expert analysis to provide a comprehensive view of how a disease evolves, how large the opportunity is, and how clinical and commercial dynamics shape decision making across the product lifecycle.
Disease Intelligence & Analytics delivers expert‑curated intelligence across epidemiology, treatment pathways, competitive landscapes, unmet need, patient segmentation, and long‑range forecasts. It brings together the essential elements teams need to size markets, understand disease evolution, and guide strategic decisions across the product lifecycle.
Disease Intelligence & Analytics is built by a multidisciplinary team of epidemiologists, therapy‑area experts, pharmacists, and analysts who validate every assumption and data point. Unlike generic datasets or automated outputs, Disease Intelligence & Analytics offers transparent methodologies, rigorous modeling, and expert interpretation—ensuring insights are both credible and actionable.
Yes. Disease Intelligence & Analytics integrates patient population forecasts, treatment dynamics, competitive movement, unmet need, and emerging therapy trends—helping teams identify the most attractive indications, quantify opportunity size, and prioritize investments with confidence.
Disease Intelligence & Analytics is a platform that brings together patient, market, and disease-level insights to support strategic decision-making. DRG Epidemiology Intelligence focuses on patient population data and forecasts, while DRG Market Assessment provides insight into treatment dynamics and market evolution. Together, they form complementary components within the DI&A platform, delivering a connected view to help teams prioritize opportunities and make confident decisions.
Get the full story of a disease
Enhance your disease strategy today
